Actinomycin D inhibited the yield of influenza virus hemagglutinin from MDCK cells infected at high multiplicity, but had little effect on the yield of parainfluenza virus hemagglutinin. In similar hemagglutinin yield experiments, ribavirin was only slightly more active (threefold) against influenza virus than against parainfluenza virus replication. In plaque inhibition experiments, ribavirin depressed influenza virus plaque formation by 50% at a concentration of approximately 3 jLg/ml, whereas the corresponding figure for parainfluenza viruses was threefold higher. The concentration of ribavirin demonstrating anti-influenza activity was indistinguishable from that inhibiting host cell growth. It is concluded that, unlike actinomycin D, ribavirin is unlikely to have a major effect on the provision of host cell 5'-terminal methylated cap structures and the subsequent priming of influenza messenger ribonucleic acid synthesis.
Ribavirin is a nucleoside analog which inhibits the replication of both deoxyribonucleic acid and ribonucleic acid (RNA) viruses including many myxoviruses (2, 5, 9, (12) (13) (14) (15) (16) (17) (18) . It has been suggested that the major route of activation of ribavirin is mediated by the host cell enzyme adenosine kinase which phosphorylates ribavirin (19) . It is thought that once inside the cell, ribavirin, as the 5'-phosphate, inhibits the host cell enzyme inosine monophosphate dehydrogenase, thus causing a depletion of the cellular guanosine nucleotide pools (16) . In accord with these suggestions, ribavirin has been shown to interfere with RNA synthesis in uninfected cells (5, 11) , although some reports have indicated that ribavirin has specific antiviral effect (6, 12, 13 (1, 10) . Ribavirin has been shown to inhibit capping of vaccinia and Venezuelan equine encephalitis virus mRNA's (4, 7), although this mechanism of action does not appear to be specifically antiviral (4). It was not possible on the basis of the data previously obtained in the influenza virus/MDCK cell system (2) to determine whether ribavirin did indeed interfere with host-mediated capping of influenza mRNA (by primer depletion) or whether inhibition of replication was simply due to decreased availability of guanosine nucleotides (11, 16) , causing a general inhibition of RNA synthesis. Both mechanisms would be expected to have the same apparent effect on viral protein synthesis (2) . This report attempts to distinguish which mechanism is important in the mode of action of ribavirin in the influenza virus/MDCK cell system. The experiments below describe a comparison of the effect of ribavirin on the replication of influenza and parainfluenza viruses in MDCK cells. Further experiments were carried out to determine the effect of ribavirin on virus replication over several replicative cycles after infection at low multiplicity. Two influenza and two parainfluenza viruses were used to confirm the generality of any differential effect (Table 2 ). It was found that plaque formation by the influenza viruses was also approximately threefold more sensitive to ribavirin than parainfluenza plaque formation.
Anti-host cell activity of ribavirin. The relatively small differential effect of ribavirin on virus replication (Tables 1 and 2 ) might be interpreted as evidence of antiviral specificity; however, it was previously demonstrated that the anti-influenza and anti-host cell activities of ribavirin are coincident, at least during the 6 h after virus infection (2) . To interpret the data in Table 2 it was necessary to determine whether this relationship was maintained over the period required for virus plaquing. The Where appropriate the inoculum contained actinomycin D or ribavirin. Virus was adsorbed for 1 h at 35°C. Cultures were rinsed three times with 1 ml of warm phosphate-buffered saline and then incubated at 35°C for 9 h (influenza virus) or 24 h (parainfluenza I virus) in Eagle minimal essential medium containing 1.1 mg of NaHCO3 per ml. Medium contained inhibitors where appropriate. The medium was sampled and assayed for hemagglutination activity using chicken red blood cells. The hemagglutinin titer per 0.25 ml is expressed as 10g2
of the reciprocal of the dilution at the endpoint of the titration. Variation (±) was calculated as the standard error of the mean. Uninfected cultures did not contain detectable hemagglutination activity. b Number of independent experiments used to obtain each value. Triplicate cultures were used in each independent experiment. VOL. 19, 1981 on October 25, 2017 by guest http://aac.asm.org/ a Confluent MDCK cell monolayers were infected with approximately 50 PFU of the appropriate virus. Virus was adsorbed for 1 h at room temperature. After adsorption the monolayers were overlaid with Eagle minimal essential medium containing NaHCO3 (1.1 mg/ml), 0.9% indubiose, penicillin (100 IU/ml), streptomycin (100 tig/ml), trypsin (1 ,ug/ml), and diethylaminoethyl-dextran (30 Ag/ml). The overlay contained ribavirin at 0.3 to 100 ,.g/ml where appropriate. Cultures were incubated for 2 (influenza) or 5 to 7 (parainfluenza) days at 35°C before fuixng with 4% formaldehyde solution in phosphate-buffered saline and plaque counting. Variation (±) is described in Table 1 . The 50% inhibitory dose is that concentration of ribavirin causing a 50% inhibition in number of plaques formed.
'See footnote b, Table 1 . MDCK cells showed only a small differential effect (Tables 1 and 2 ), unlike that exhibited by actinomycin D (1) . Although the quantitative effect of ribavirin on influenza virus plaquing in this study (Table 2) agrees well with some earlier findings (8, 12) , reports on the relative effectiveness of ribavirin against influenza and parainfluenza viruses do appear to vary (9, 14, 17) . The reason for this discrepancy is unclear at present. It would appear that, as it exerts only a slight differential effect on myxovirus replication, ribavirin does not have a major effect on the influenza virus-specific sequestration of host cell mRNA 5'-terminal cap structures (10) . It seems probable, considering the coincidence of antiviral and anti-host cell activity of ribavirin in the MDCK cell system (Tables 1 to 3 ; reference 2), that the replication of the myxoviruses is inhibited in the main by the reduced availability of guanosine nucleotides (11, 16) . It is possible, however, that the slightly greater (threefold) sensitivity of influenza virus is due to its direct reliance on host cell mRNA synthesis (10) acting in addition to nucleotide depletion. Further studies at the molecular level will be required to substantiate these suggestions.
